IDEXX Laboratories Inc. 8-K Filing Report - Key Financial Insights

$IDXX
Form 8-K
Filed on: 2025-10-07
Source
IDEXX Laboratories Inc. 8-K Filing Report - Key Financial Insights

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Name: IDEXX Laboratories Inc.
  • CIK: 0000874716
  • Address: One IDEXX Drive, Westbrook, ME 04092
  • Stock Symbol: IDXX
  • Exchange: NASDAQ
  1. Filing Information:
  • Filing Type: 8-K
  • Filing Date: October 6, 2025
  • SEC File Number: 000-19271
  • IRS Number: 01-0393723
  1. Financial Metrics:
  • Common Stock:
    • Par Value: $0.10 per share
  • Measurement Units:
    • Currency: USD (US Dollars)
    • Shares: Denoted as shares
    • Share Value: USD per Share (USDPShares)
  1. Context:
  • Reporting Period: As of October 6, 2025
  • Context ID: AsOf2025-10-06

Insights:

  • The report indicates that IDEXX Laboratories Inc. is actively filing relevant updates with the SEC, as evidenced by the 8-K filing, which is used to report unscheduled material events or corporate changes.
  • The presence of the stock symbol and its listing on NASDAQ suggests that IDEXX is a publicly traded company, which may attract investor interest and market analysis.
  • The common stock's par value of $0.10 indicates a low nominal value per share, which can be typical for companies that may have significant retained earnings and a higher market price per share.

Overall, this section of the financial report provides a snapshot of IDEXX Laboratories Inc.'s corporate identity, recent regulatory compliance actions, and basic stock information. Further analysis would require additional details about the content of the 8-K filing to understand the material event or information being reported.